A novel non-toxic camptothecin formulation for cancer chemotherapy

Saved in:
Bibliographic Details
Title: A novel non-toxic camptothecin formulation for cancer chemotherapy
Authors: Berrada, M.1, Serreqi, A.1, Dabbarh, F1, Owusu, A.2, Gupta, A.1, Lehnert, S.2 shirley.lehnert@mcgill.ca
Source: Biomaterials. May2005, Vol. 26 Issue 14, p2115-2120. 6p.
Subjects: Cancer treatment, Antineoplastic agents, Antiviral agents, Alkaloids
Abstract: The use of a novel injectable biocompatible and biodegradable camptothecin-polymer implant for sustained intra-tumoral release of high concentrations of camptothecin is described. The drug delivery vehicle is an in situ thermogelling formulation, which is based on the natural biopolymer chitosan. This formulation, containing homogeneously dispersed camptothecin, was implanted intra-tumorally into a sub-cutaneous mouse tumor model (RIF-l). The effectiveness of treatment was measured in terms of tumor growth delay (TGD). Animals treated with the polymer implants containing camptothecin had significantly longer TGDs compared to untreated animals as well as to animals treated systemically with camptothecin by intra-peritoneal injection with no evidence of toxicity in terms of loss of body weight. The results indicate that this novel biodegradable polymer implant is an effective vehicle for the sustained intra-tumoral delivery of camptothecin which might also be suitable to deliver other insoluble anti-cancer drugs such as taxol. [Copyright &y& Elsevier]
Copyright of Biomaterials is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
FullText Text:
  Availability: 0
Header DbId: egs
DbLabel: Engineering Source
An: 15825969
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A novel non-toxic camptothecin formulation for cancer chemotherapy
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Berrada%2C+M%2E%22">Berrada, M.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Serreqi%2C+A%2E%22">Serreqi, A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Dabbarh%2C+F%22">Dabbarh, F</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Owusu%2C+A%2E%22">Owusu, A.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Gupta%2C+A%2E%22">Gupta, A.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Lehnert%2C+S%2E%22">Lehnert, S.</searchLink><relatesTo>2</relatesTo><i> shirley.lehnert@mcgill.ca</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Biomaterials%22">Biomaterials</searchLink>. May2005, Vol. 26 Issue 14, p2115-2120. 6p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Cancer+treatment%22">Cancer treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Antineoplastic+agents%22">Antineoplastic agents</searchLink><br /><searchLink fieldCode="DE" term="%22Antiviral+agents%22">Antiviral agents</searchLink><br /><searchLink fieldCode="DE" term="%22Alkaloids%22">Alkaloids</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The use of a novel injectable biocompatible and biodegradable camptothecin-polymer implant for sustained intra-tumoral release of high concentrations of camptothecin is described. The drug delivery vehicle is an in situ thermogelling formulation, which is based on the natural biopolymer chitosan. This formulation, containing homogeneously dispersed camptothecin, was implanted intra-tumorally into a sub-cutaneous mouse tumor model (RIF-l). The effectiveness of treatment was measured in terms of tumor growth delay (TGD). Animals treated with the polymer implants containing camptothecin had significantly longer TGDs compared to untreated animals as well as to animals treated systemically with camptothecin by intra-peritoneal injection with no evidence of toxicity in terms of loss of body weight. The results indicate that this novel biodegradable polymer implant is an effective vehicle for the sustained intra-tumoral delivery of camptothecin which might also be suitable to deliver other insoluble anti-cancer drugs such as taxol. [Copyright &y& Elsevier]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Biomaterials is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=15825969
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.biomaterials.2004.06.013
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 2115
    Subjects:
      – SubjectFull: Cancer treatment
        Type: general
      – SubjectFull: Antineoplastic agents
        Type: general
      – SubjectFull: Antiviral agents
        Type: general
      – SubjectFull: Alkaloids
        Type: general
    Titles:
      – TitleFull: A novel non-toxic camptothecin formulation for cancer chemotherapy
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Berrada, M.
      – PersonEntity:
          Name:
            NameFull: Serreqi, A.
      – PersonEntity:
          Name:
            NameFull: Dabbarh, F
      – PersonEntity:
          Name:
            NameFull: Owusu, A.
      – PersonEntity:
          Name:
            NameFull: Gupta, A.
      – PersonEntity:
          Name:
            NameFull: Lehnert, S.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 05
              Text: May2005
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 01429612
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: Biomaterials
              Type: main
ResultId 1